Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Sep 15, 2014 · 10-Q · 77 days after period end · 0001557240-14-000510
| Metric | Q2 2014 | Q2 2012 |
|---|---|---|
| Net Income | -$142.92K | -$381.00 |
| EPS Diluted | -$0.02 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Sep 15, 2014 · 77 d after period end
